A new study has mapped the effects of ketamine on the brain, finding that repeated use over extended periods creates...
MGC Pharmaceuticals has received permission to import psilocybin into Slovenia.
Kernel has published results from its Cybin-sponsored neuroimaging study which show the ability of Kernel’s Flow1 system to capture and analyse brain changes induced by psychedelics.
Adaptogens are herbs, roots and other plant substances (like mushrooms) that help our bodies manage stress and restore balance after a stressful situation.
A low-cost version of ketamine has shown promising results in its treatment of resistant depression in a double-blind trial.
As their 300-gram MDMA shipment got to the border, PharmAla Biotech found themselves in a sticky situation.
The Psychedelic Access and Research Alliance (PAREA) has released a position statement calling on the EU to harness psychedelics in a bid to create innovation in...
A group of doctors are urging researchers to look at psychedelics to ease the often overwhelming distress faced by women with late-stage gynaecological cancers.
For thousands of years, indigenous societies in Mexico and Central America have used psychedelics for medicinal, spiritual, and cultural purposes.
With an explosion in research looking at psychedelic therapy for a number of mental health conditions, FDA approval for MDMA-assisted psychotherapy for PTSD is anticipated for...
A donation of $1.5 million has been gifted to the UC San Diego Psychedelics and Health Research Initiative to research DMT by philanthropist Eugene Jhong.
Until now, it has been commonly thought that selective serotonin reuptake inhibitors (SSRIs) could interfere with the therapeutic potential of psilocybin treatment.
A group of experts has published a paper in the American Journal of Psychiatry examining the definition of “psychedelic-assisted psychotherapy” using psilocybin.